Health care stocks were declining pre-bell Thursday, with The Health Care Select Sector SPDR Fund (XLV) down 0.9% and the iShares Biotechnology ETF (IBB) 0.7% lower.
Takeda Pharmaceutical (TAK) shares were down more than 0.5% after the company reported lower fiscal Q4 core earnings.
Argenx (ARGX) stock was more than 8% lower after the company posted operating income that trailed analysts' expectations.
Stevanato Group (STVN) shares were up over 1% after the company reported higher Q1 adjusted earnings and revenue.